⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked sharesUnlock shares

Hanover stock maintains Outperform as BMO sees benefits from broker partnerships

EditorAhmed Abdulazez Abdulkadir
Published 20/12/2024, 04:28 am
THG
-

On Thursday, BMO Capital Markets adjusted its outlook on The Hanover Insurance Group (NYSE:THG), increasing the stock's price target from $161.00 to $180.00. The firm maintained its Outperform rating on the shares. The insurance provider, with a market capitalization of $5.5 billion, has shown strong momentum with a 26.8% gain year-to-date. According to InvestingPro data, multiple analysts have revised their earnings estimates upward for the upcoming period.

The revision follows recent meetings with Hanover's CFO, Jeff Farber, and Bryan Salvatore, President of Specialty Commercial. The analyst highlighted that the new price target and a slight increase in earnings estimates are due to anticipated higher investment income and adjustments to expected share repurchase levels.

The firm projects share repurchases of $100 million and $140 million for the years 2025 and 2026, respectively. The company maintains a solid financial position, with InvestingPro analysis indicating a "GOOD" overall financial health score and a consistent track record of maintaining dividend payments for 20 consecutive years.

The analyst also noted a potential increase in the personal lines expense ratio. This is attributed to The Hanover Insurance Group's significant home insurance improvement initiative, which is expected to yield positive results. As part of this initiative, the company may pay higher profit-share commissions to its broker agents.

The Hanover Insurance Group's strategic moves are aimed at strengthening its market position and financial performance. The analyst's updated estimates reflect a confidence in the company's ability to generate higher returns for its shareholders through these initiatives.

The report suggests that The Hanover Insurance Group is poised for growth, backed by solid financial strategies and operational enhancements. The increased price target signals the analyst's belief in the company's potential for improved financial outcomes in the coming years.

In other recent news, The Hanover Insurance Group has been making notable strides. Morgan Stanley (NYSE:MS) initiated coverage on the company with an Equalweight rating, noting the company's potential to meet its long-term financial goals despite setbacks in its Personal Lines business.

The company's ability to achieve a 14% long-term return on equity, over 7% net premium written growth, 12-13% earnings per share growth, and 7-8% book value per share growth were highlighted as central to the investment thesis.

In addition to these developments, Hanover Insurance recently reported a strong Q3 performance. The company achieved an operating income of $3.5 per diluted share and a return on equity of 14.4%. The combined ratio, excluding catastrophe losses, reached an impressive 88.3%. Growth was observed in the Personal Lines segment, led by auto insurance, while the Specialty segment saw a combined ratio increase due to higher expenses.

Looking ahead, Hanover Insurance's management expects net written premium growth over 6% in the fourth quarter and an expense ratio of approximately 30.9% for the full year. The company aims to maintain a combined ratio below 90% and achieve net written premium growth over 6% in Q4.

Furthermore, the company projects an expense ratio of approximately 30.9% for the full year, with a target of 30.5% for 2025. Analyst Mike Zaremski confirmed that the ex-cat combined ratio is expected to be below 90%, specifically in the high 88s range year-to-date.

Despite competitive market conditions and recent hurricanes, The Hanover Insurance Group's proactive strategies position it well for continued growth and profitability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.